Fatty Liver Disease (NASH) Clinical Research Study Enrolling Now in West Palm Beach FL
The SYNCHRONY Histology study is a clinical study to see what effect an investigational drug, EFX, has on scarring of the liver in NASH. AII participants will need to have NASH shown in a liver biopsy (sample of liver tissue). The biopsy may be obtained previously (within 180 days of screening visit), or during the screening process.
We are looking for adults 18 – 80 years of age who have been diagnosed with fatty liver (NASH) and fibrosis. The clinical research study will evaluate the safety and effectiveness of an investigational drug on scarring of the liver in NASH.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/nash-clinical-trial/
Clinical study enrolling now in West Palm Beach, FL
ACHIEVE – 3
ACHIEVE-3 is a clinical research study for people with Type 2 Diabetes who are being treated with metformin.
The study will test if an investigational medicine (the medicine being studied) can help with blood glucose (sugar) and weight management compared with an existing treatment for Type 2 diabetes.
For more information, or to see if you qualify to participate in this study, please call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/dm2-on-metformin.
Consider joining a clinical research study enrolling now in West Palm Beach, FL.
Researchers are currently enrolling adult volunteers in a clinical research study evaluating the safety and effectiveness of an investigational medication for the treatment of Diabetic Peripheral Neuropathy.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/dpn/
Learn more about the new study for adults with high triglyceride levels.
The purpose of the study is to evaluate the safety and effectiveness of an investigational oral medication in reducing high triglyceride levels.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute, Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/high-triglycerides/
